☆ 4.8 Editorial Material

Preventing Anthracycline-Induced Cardiotoxicity Using Functional Genomics and Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes

CIRCULATION (2022)

Related references

Note: Only part of the references are listed.

Article Cardiac & Cardiovascular Systems

Identification of Drug Transporter Genomic Variants and Inhibitors That Protect Against Doxorubicin-Induced Cardiotoxicity

Tarek Magdy et al.

Summary: This study demonstrates the cardioprotective effect of the SLC28A3 locus using human induced pluripotent stem cell model. It also identifies a novel cardioprotective single nucleotide polymorphism and a competitive inhibitor, desipramine, against doxorubicin-induced cardiotoxicity.

CIRCULATION (2022)

Add to Collection

Article Psychiatry

CRISPR-based functional evaluation of schizophrenia risk variants

Prashanth Rajarajan et al.

SCHIZOPHRENIA RESEARCH (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Unveiling the Role of the Most Impactful Cardiovascular Risk Locus through Haplotype Editing

Valentina Lo Sardo et al.

CELL (2018)

Add to Collection

Article Biochemistry & Molecular Biology

A Genetic Variant Associated with Five Vascular Diseases Is a Distal Regulator of Endothelin-1 Gene Expression

Rajat M. Gupta et al.

CELL (2017)

Add to Collection

Letter Pharmacology & Pharmacy

Pharmacogenomic screening for anthracycline-induced cardiotoxicity in childhood cancer

Folefac Aminkeng et al.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2017)

Add to Collection

Review Pharmacology & Pharmacy

Validating the pharmacogenomics of chemotherapy-induced cardiotoxicity: What is missing?

Tarek Magdy et al.

PHARMACOLOGY & THERAPEUTICS (2016)

Add to Collection

Article Oncology

Pharmacogenomic Prediction of Anthracycline-Induced Cardiotoxicity in Children

Henk Visscher et al.

JOURNAL OF CLINICAL ONCOLOGY (2012)

Add to Collection

© Peeref 2019-2024. All rights reserved.